Cargando…

Oncometabolites—A Link between Cancer Cells and Tumor Microenvironment

SIMPLE SUMMARY: Lactate, glutamate, fumarate, and succinate are metabolites that accumulate in tumors as a consequence of an alteration in cellular respiration connected with malignant transformation. These metabolites link all types of cells involved in tumor survival and progression, so they are a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baryła, Maksymilian, Semeniuk-Wojtaś, Aleksandra, Róg, Letycja, Kraj, Leszek, Małyszko, Maciej, Stec, Rafał
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869548/ https://www.ncbi.nlm.nih.gov/pubmed/35205136 http://dx.doi.org/10.3390/biology11020270

Ejemplares similares

The immune landscape of hepatocellular carcinoma-where we are?
por: Gryziak, Maciej, et al.
Publicado: (2022)

Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2023)

Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer Patients
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2016)

Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer
por: Semeniuk-Wojtaś, Aleksandra, et al.
Publicado: (2020)

Intensity of Nuclear Staining for Ki-67, p53 and Survivin as a New Prognostic Factor in Non-muscle Invasive Bladder Cancer
por: Stec, Rafał, et al.
Publicado: (2019)

Kynurenine: an oncometabolite in colon cancer
por: Venkateswaran, Niranjan, et al.
Publicado: (2020)

Oncometabolite modification of Keap1 links GSTZ1 deficiency with cancer
por: Guo, Weijie, et al.
Publicado: (2019)

Oncometabolites and the response to radiotherapy
por: Xiang, Kexu, et al.
Publicado: (2020)

The emerging role of fumarate as an oncometabolite
por: Yang, Ming, et al.
Publicado: (2012)

Oncometabolites: tailoring our genes
por: Nowicki, Stefan, et al.
Publicado: (2015)

Metabolic Rewiring and the Characterization of Oncometabolites
por: Beyoğlu, Diren, et al.
Publicado: (2021)

Role of succinate dehydrogenase deficiency and oncometabolites in gastrointestinal stromal tumors
por: Zhao, Yue, et al.
Publicado: (2020)

A chemoproteomic portrait of the oncometabolite fumarate
por: Kulkarni, Rhushikesh A., et al.
Publicado: (2019)

Oncometabolites: A new insight for oncology
por: Khatami, Fatemeh, et al.
Publicado: (2019)

Oncometabolites as biomarkers in thyroid cancer: a systematic review
por: Khatami, Fatemeh, et al.
Publicado: (2019)

SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
por: Chan, Ti-Chun, et al.
Publicado: (2020)

Oncometabolites: Unconventional triggers of oncogenic signalling cascades
por: Sciacovelli, Marco, et al.
Publicado: (2016)

Oncometabolite induced primary cilia loss in pheochromocytoma
por: O’Toole, Samuel M, et al.
Publicado: (2018)

Targeting Oncometabolites in Peritoneal Cancers: Preclinical Insights and Therapeutic Strategies
por: Nadhan, Revathy, et al.
Publicado: (2023)

Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019)

Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?
por: Małyszko, Jolanta, et al.
Publicado: (2017)

Another small molecule in the oncometabolite mix: L-2-Hydroxyglutarate in kidney cancer
por: Shim, Eun-Hee, et al.
Publicado: (2015)

Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
por: Corrado, Mauro, et al.
Publicado: (2016)

Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
por: Zhou, Zhengqiu, et al.
Publicado: (2018)

Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
por: Godel, Martina, et al.
Publicado: (2021)

Human Phosphoglycerate Dehydrogenase Produces the Oncometabolite d-2-Hydroxyglutarate
por: Fan, Jing, et al.
Publicado: (2014)

The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway
por: Carbonneau, Mélissa, et al.
Publicado: (2016)

Oncometabolites suppress DNA repair by disrupting local chromatin signaling
por: Sulkowski, Parker L., et al.
Publicado: (2020)

Imaging 2-hydroxyglutarate and other brain oncometabolites pertinent to critical genomic alterations in brain tumors
por: Thomas, Teena, et al.
Publicado: (2023)

Test of lepton universality inside the $J/\psi$ region as a basis for further research away from charmonium resonances
por: Wojtas, Maksymilian
Publicado: (2017)

From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
por: Di Gregorio, Emanuela, et al.
Publicado: (2021)

Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression
por: Li, Zhongchi, et al.
Publicado: (2022)

Defining Tumor Microenvironment as a Possible Target for Effective GEP-NENs Immunotherapy—A Systematic Review
por: Chmiel, Paulina, et al.
Publicado: (2023)

The Enzymology of 2-Hydroxyglutarate, 2-Hydroxyglutaramate and 2-Hydroxysuccinamate and Their Relationship to Oncometabolites
por: Hariharan, Vivek A., et al.
Publicado: (2017)

Tumor cell–derived spermidine is an oncometabolite that suppresses TCR clustering for intratumoral CD8(+) T cell activation
por: Hibino, Sana, et al.
Publicado: (2023)

Hypertension in malignancy–an underappreciated problem
por: Małyszko, Jolanta, et al.
Publicado: (2018)

Cytidine deaminase deficiency in tumor cells is associated with sensitivity to a naphthol derivative and a decrease in oncometabolite levels
por: Mameri, Hamza, et al.
Publicado: (2022)

The oncometabolite 2-hydroxyglutarate produced by mutant IDH1 sensitizes cells to ferroptosis
por: Wang, Tian-Xiang, et al.
Publicado: (2019)

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
por: Berger, Raffaela S., et al.
Publicado: (2021)

Links Between N (6)-Methyladenosine and Tumor Microenvironments in Colorectal Cancer
por: Zhang, Yundi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1ov09fvuu54scv8u7b3ag1p4ku